Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view
- PMID: 26161930
- DOI: 10.2217/fon.15.91
Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view
Abstract
Clinical oncology is facing a paradigm shift. A new treatment philosophy is emerging and new targets are appearing that require new active agents. The medical use of nanotechnology - nanomedicine - holds several promising possibilities in the war against cancer. Some of these include: new formats for old drugs, that is, increasing efficacy while diminishing side effects; and new administration routes - that is, dermal, oral and pulmonary. In this overview, we describe some nanoparticles and their medical uses as well as highlight advantages of nanoparticles compared with conventional pharmaceuticals. We also point to some of the many technical challenges and potential risks with using nanotechnology for oncological applications.
Keywords: cancer; clinical oncology; nanomedicine; nanoparticles; therapy.
Similar articles
-
Nanoparticles for cancer therapy using magnetic forces.Nanomedicine (Lond). 2012 Mar;7(3):447-57. doi: 10.2217/nnm.12.10. Nanomedicine (Lond). 2012. PMID: 22385201 Review.
-
Unique benefits of nanotechnology to drug delivery and diagnostics.Methods Mol Biol. 2011;697:3-8. doi: 10.1007/978-1-60327-198-1_1. Methods Mol Biol. 2011. PMID: 21116949
-
Nanometric gold in cancer nanotechnology: current status and future prospect.J Pharm Pharmacol. 2013 May;65(5):634-51. doi: 10.1111/jphp.12017. Epub 2012 Dec 24. J Pharm Pharmacol. 2013. PMID: 23600380 Review.
-
Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.Br J Ophthalmol. 2014 Apr;98(4):427-31. doi: 10.1136/bjophthalmol-2013-304028. Epub 2013 Nov 18. Br J Ophthalmol. 2014. PMID: 24246373 Review.
-
Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy.Drug Discov Today. 2012 Sep;17(17-18):1044-52. doi: 10.1016/j.drudis.2012.05.010. Epub 2012 May 29. Drug Discov Today. 2012. PMID: 22652342 Review.
Cited by
-
Targeting and isolation of cancer cells using micro/nanomotors.Adv Drug Deliv Rev. 2018 Feb 1;125:94-101. doi: 10.1016/j.addr.2017.09.002. Epub 2017 Sep 9. Adv Drug Deliv Rev. 2018. PMID: 28893551 Free PMC article. Review.
-
Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models.Int J Nanomedicine. 2016 Dec 12;11:6703-6712. doi: 10.2147/IJN.S121156. eCollection 2016. Int J Nanomedicine. 2016. PMID: 28003746 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources